Nicolai Jørgensen

发表

Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial.

I. Svane, N. Abildgaard, L. Knudsen, 2016, Stem cell investigation.

Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial

L. Olsen, I. Svane, T. Klausen, 2020, Frontiers in Immunology.